BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 31328143)

  • 1. [Successful cord blood transplantation for refractory gamma-delta hepatosplenic T-cell lymphoma developed during treatment of Crohn's disease].
    Saito A; Nara M; Fujishima T; Kuroki W; Yamashita T; Kobayashi T; Ikeda S; Kitadate A; Kameoka Y; Takahashi N
    Rinsho Ketsueki; 2024; 65(1):41-46. PubMed ID: 38311388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A primary hepatic lymphoma in a patient with Crohn's disease receiving thiopurine and anti-TNF therapy: a case report.
    Merhaben S; Ayadi S; Tangour M; Boujelbene N; Ghariani R; Mouelhi L; Merhaben F
    Future Sci OA; 2023 Dec; 9(10):FSO893. PubMed ID: 37753362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatosplenic Alpha-Beta T-Cell Lymphoma: A Challenging Diagnostic Entity.
    Gabra A; Polanco J; Thapa S; Sawhney S; Glazyrin A
    J Hematol; 2024 Apr; 13(1-2):29-33. PubMed ID: 38644989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Squamous cell carcinoma and Crohn's disease: a sometimes-challenging diagnosis.
    Boudabbous M; Barkia B; Feki W; Gdoura H; Chtourou L; Moalla M; Mnif L; Amouri A; Mnif Z; Tahri N
    Future Sci OA; 2024; 10(1):FSO907. PubMed ID: 38827804
    [No Abstract]   [Full Text] [Related]  

  • 5. Ethnicity and socio-economic status affects the incidence and survival of hepatosplenic T-cell lymphoma.
    Bishton MJ; Crooks CJ; Card TR; West J
    Br J Haematol; 2024 Feb; ():. PubMed ID: 38420697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A challenging diagnosis of hepatosplenic T cell lymphoma in a 10-year-old child.
    Ali SK; Alomar SA; Salih HM; Yaseen NS
    Blood Res; 2023 Sep; 58(3):157-161. PubMed ID: 37751923
    [No Abstract]   [Full Text] [Related]  

  • 7. Hepatosplenic fusion: an extremely rare finding.
    Humaran Cozar D; Galofré Recasens M; Busquets Carrera O; Torres Marí A
    Cir Esp (Engl Ed); 2024 Feb; ():. PubMed ID: 38382742
    [No Abstract]   [Full Text] [Related]  

  • 8. Risk of Lymphoma Associated with Anti-TNF Therapy in Patients with Inflammatory Bowel Disease: Implications for Therapy.
    Dahmus J; Rosario M; Clarke K
    Clin Exp Gastroenterol; 2020; 13():339-350. PubMed ID: 32982364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of chidamide on treating hepatosplenic T-cell lymphoma: A case report.
    Wang XT; Guo W; Sun M; Han W; Du ZH; Wang XX; Du BB; Bai O
    World J Clin Cases; 2020 Jul; 8(14):3122-3129. PubMed ID: 32775395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T-cell non-Hodgkin's lymphomas reported to the FDA AERS with tumor necrosis factor-alpha (TNF-α) inhibitors: results of the REFURBISH study.
    Deepak P; Sifuentes H; Sherid M; Stobaugh D; Sadozai Y; Ehrenpreis ED
    Am J Gastroenterol; 2013 Jan; 108(1):99-105. PubMed ID: 23032984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of case reports and the Adverse Event Reporting System in systematic reviews: overcoming barriers to assess the link between Crohn's disease medications and hepatosplenic T-cell lymphoma.
    Selvaraj SA; Chairez E; Wilson LM; Lazarev M; Bass EB; Hutfless S
    Syst Rev; 2013 Jul; 2():53. PubMed ID: 23826928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatosplenic T-Cell Lymphoma: A Rare Complication of Monotherapy with Thiopurines in Crohn's Disease.
    Carvão J; Magno Pereira V; Jacinto F; Sousa Andrade C; Jasmins L
    GE Port J Gastroenterol; 2019 Jul; 26(4):279-284. PubMed ID: 31328143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatosplenic T-cell lymphoma in a 47-year-old Crohn's disease patient on thiopurine monotherapy.
    van de Meeberg MM; Derikx LA; Sinnige HA; Nooijen P; Schipper DL; Nissen LH
    World J Gastroenterol; 2016 Dec; 22(47):10465-10470. PubMed ID: 28058028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatosplenic T-cell lymphoma in a young man with Crohn's disease: case report and literature review.
    Ochenrider MG; Patterson DJ; Aboulafia DM
    Clin Lymphoma Myeloma Leuk; 2010 Apr; 10(2):144-8. PubMed ID: 20371449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A systematic review of factors that contribute to hepatosplenic T-cell lymphoma in patients with inflammatory bowel disease.
    Kotlyar DS; Osterman MT; Diamond RH; Porter D; Blonski WC; Wasik M; Sampat S; Mendizabal M; Lin MV; Lichtenstein GR
    Clin Gastroenterol Hepatol; 2011 Jan; 9(1):36-41.e1. PubMed ID: 20888436
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.